NCT02778464View on ClinicalTrials.gov

Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 8, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions

Inflammatory Bowel Disease (IBD)Crohn's Disease (CD)Ulcerative Colitis (UC)Pregnancy

Trial Locations (1)

WV10 0QP

The Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors

lead

The Royal Wolverhampton Hospitals NHS Trust

OTHER_GOV

NCT02778464 - Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter